Evidence mapPaperPMID 42205159Full record

ArticleBrain communications2026

A minimally invasive, scalable and reproducible neonatal rat model of severe focal brain injury.

Victor Mondal, Emily Ross-Munro, Gayathri K Balasuriya, Ritu Kumari, Isabelle K Shearer, Andjela Micic, Abdullah Al Mamun Sohag, Alan Shi, Mikaela Barresi, David R Nisbet and 8 more

Abstract read
In one paragraph

Article in Brain communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Victor MondalSchool of Health and Biomedical Sciences, RMIT University, Bundoora, Melbourne, Victoria 3083, Australia.ORCID https://orcid.org/0009-0003-3189-8124
Emily Ross-MunroSchool of Health and Biomedical Sciences, RMIT University, Bundoora, Melbourne, Victoria 3083, Australia.
Gayathri K BalasuriyaSchool of Health and Biomedical Sciences, RMIT University, Bundoora, Melbourne, Victoria 3083, Australia.
Ritu KumariSchool of Health and Biomedical Sciences, RMIT University, Bundoora, Melbourne, Victoria 3083, Australia.
Isabelle K ShearerSchool of Health and Biomedical Sciences, RMIT University, Bundoora, Melbourne, Victoria 3083, Australia.ORCID https://orcid.org/0009-0009-3437-6915
Andjela MicicSchool of Health and Biomedical Sciences, RMIT University, Bundoora, Melbourne, Victoria 3083, Australia.
Abdullah Al Mamun SohagSchool of Health and Biomedical Sciences, RMIT University, Bundoora, Melbourne, Victoria 3083, Australia.
Alan ShiSchool of Health and Biomedical Sciences, RMIT University, Bundoora, Melbourne, Victoria 3083, Australia.
Mikaela BarresiSchool of Health and Biomedical Sciences, RMIT University, Bundoora, Melbourne, Victoria 3083, Australia.ORCID https://orcid.org/0000-0001-5365-5113
David R NisbetAikenhead Centre for Medical Discovery, St Vincent's Hospital, Fitzroy, Melbourne, Victoria 3065, Australia.
Glenn F KingInstitute for Molecular Bioscience, The University of Queensland, St Lucia, Queensland 4072, Australia.ORCID https://orcid.org/0000-0002-2308-2200
Richard J WilliamsSchool of Health and Biomedical Sciences, RMIT University, Bundoora, Melbourne, Victoria 3083, Australia.
Pierre GressensUniversité Paris Cité, Inserm, NeuroDiderot, Paris 75019, France.
Flora Y WongMonash Newborn, Monash Children's Hospital and Department of Paediatrics, Monash University, Melbourne, Victoria 3168, Australia.ORCID https://orcid.org/0000-0002-8265-2330
Jeanie L Y CheongClinical Sciences, Murdoch Children's Research Institute, Parkville, Melbourne, Victoria 3052, Australia.ORCID https://orcid.org/0000-0001-5901-0455
David W WalkerSchool of Health and Biomedical Sciences, RMIT University, Bundoora, Melbourne, Victoria 3083, Australia.ORCID https://orcid.org/0000-0002-4958-6140
Mary TolcosSchool of Health and Biomedical Sciences, RMIT University, Bundoora, Melbourne, Victoria 3083, Australia.ORCID https://orcid.org/0000-0001-6105-4553
Bobbi FleissSchool of Health and Biomedical Sciences, RMIT University, Bundoora, Melbourne, Victoria 3083, Australia.ORCID https://orcid.org/0000-0001-7828-673X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neonatal brain injuries, such as stroke, cause focal ischaemic lesions that often result in lifelong neurological disabilities, yet effective treatments remain limited. Early-phase therapeutic screening requires models that can reliably reproduce injury severity while minimising confounding variables, including prolonged or variable anaesthesia, surgical stress, and invasive procedures that themselves affect injury progression. Existing models of neonatal focal ischaemia often exhibit high mortality, technical complexity, and substantial variability in lesion location and volume. As a result, there is a critical need for a rapid, ethically refined, and scalable neonatal model that produces consistent cortical injury suitable for screening neuroprotective, biomaterial-based, and regenerative therapies. We established a minimally invasive photothrombotic ischaemia model in postnatal day 10 rats by administering intraperitoneal Rose Bengal (25, 40, or 60 mg/kg) and activating it with a fixed 10-minute exposure to 565-nm light through the intact scalp and skull. This incision-free protocol allowed a total procedure duration of 19 min. We characterized dose-dependent effects on infarct volume and anatomical distribution, cortical atrophy, ventricular enlargement, apoptosis (cleaved caspase-3), astrocytic and microglial reactivity (glial fibrillary acidic protein, GFAP; ionized calcium-binding adapter molecule 1, Iba1), and sensorimotor outcomes (wire hang, cylinder rearing, adhesive tape removal) at 1, 7, and 14 days after injury. Additional analyses assessed the reproducibility of lesion size across litters and explored sex-specific differences. A 25 mg/kg dose induced a reliable and well-localized motor cortex infarct with no mortality. Higher doses of Rose Bengal produced proportionally larger infarcts with greater subcortical involvement and more pronounced secondary atrophy. Across all groups, apoptotic signalling and glial reactivity remained elevated through 14 days, indicating persistent tissue injury. Sensorimotor impairments were robust at all stages, with deficits in forepaw use, endurance, and tactile response correlating with lesion volumes in the 25 mg/kg group. No significant sex differences were observed for any histological or behavioural outcomes. This refined neonatal photothrombotic model provides a reproducible, simple, scalable, and ethically optimized platform for inducing severe focal cortical injury. The model's stable injury territory, short, standardized procedure, and consistent functional readouts fill a major gap in current research tools and provide a practical foundation for early-phase testing of neuroprotective and regenerative interventions.

Indexed as

ischaemianeuroinflammationperinatalstrokethrombosis

Identifiers

PMID42205159
PMCPMC13201095

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.